CS logo
small CS logo
CLL Research and Treatment Program

New Hyde Park, New York, United States
Hematologist in North New Hyde Park, New York
410 Lakeville Rd, Floral Park, NY 11005

About CLL Research and Treatment Program


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pharmacyclics LLC.
2
Total Rows: 1

Clinical Trials at CLL Research and Treatment Program


During the past decade, CLL Research and Treatment Program conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy of PCI-32765 in Participants With Relapsed/Refractory Mantle Cell Lymphoma (MCL)
2011-02-01
2014-01-01
Completed
115
Safety and Tolerability Study of PCI-32765 Combined With Fludarabine/Cyclophosphamide/Rituximab (FCR) and Bendamustine/Rituximab (BR) in Chronic Lymphocytic Leukemia (CLL)
2011-02-01
2013-05-01
Completed
33

Rows per page:

1–2 of 2

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "CLL Research and Treatment Program" #1 collaborator was "Janssen Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsPharmacyclics LLC.: 2Pharmacyclics LLC.: 2

Created with Highcharts 11.1.0Top CollaboratorsJanssen Pharmaceuticals: 1Janssen Pharmaceuticals: 1

Clinical Trials Conditions at CLL Research and Treatment Program


According to Clinical.Site data, the most researched conditions in "CLL Research and Treatment Program" are "B-cell Chronic Lymphocytic Leukemia" (1 trials), "Mantle Cell Lymphoma" (1 trials) and "Small Lymphocytic Lymphoma" (1 trials). Many other conditions were trialed in "CLL Research and Treatment Program" in a lesser frequency.

Clinical Trials Intervention Types at CLL Research and Treatment Program


Most popular intervention types in "CLL Research and Treatment Program" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "PCI-32765" (2 trials). Other intervention names were less common.

Clinical Trials Genders at CLL Research and Treatment Program


The vast majority of trials in "CLL Research and Treatment Program" are 2 trials for "All" genders.

Clinical Trials Status at CLL Research and Treatment Program


Currently, there are NaN active trials in "CLL Research and Treatment Program". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in CLL Research and Treatment Program, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in CLL Research and Treatment Program, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 1: 1Phase 1: 1Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 2Completed: 2